LifeSpot Health
  • Home
  • Board & Management
  • Products
  • FeverTelTM Store
  • Investor
  • (03) 8395 5446
Select Page

CORPORATE GOVERNANCE

https://lifespot-health.com/corporate-governance/

ANNOUNCEMENTS

04/01/2020 APPOINTMENT / RESIGNATION OF COMPANY SECRETARY
30/12/2020 RIGHTS ISSUE RESULTS & SHORTFALL NOTIFICATION
07/12/2020 OFFER DOCUMENT ENTITLEMENT ISSUE
12/10/2020 CEO appointment
12/10/2020 Private Placement and Market update
28/07/2020 FLU & COVID SYMPTOMS MONITORING LAUNCHED, SALES IN JULY
28/07/2020 Appendix 4C: Quarterly Report 30 June 2020
31/10/2018 Seng Vital – The smart vaporizer system for medical cannabis
21/03/2018 New Patient Self-Management System Launched
28/02/2018 Preliminary Final Report
31/01/2018 Appendix 4C – quarterly
01/11/2017 Lifespot Health restructures its Business and Board
31/10/2017 Appendix 4C – quarterly
07/09/2017 Lifespot Signs Global Agreement With Beurer
31/08/2017 Half Yearly Report and Accounts
31/07/2017 Appendix 4C – quarterly
28/07/2017 Digital Health Consortium Formed To Target $3.5B Market
18/05/2017 Business & Operational Update
01/05/2017 LSH enters $50Bn Global Medicinal Cannabis market
28/04/2017 Appendix 4C – quarterly
04/04/2017 Update on Medicinal Cannabis opportunities
28/03/2017 Exploring opportunities in Medicinal Cannabis
08/03/2017 Lifespot Health wins major contract & strategic b2b partner
01/03/2017 Preliminary Final Report
03/02/2017 Lifespot Health to enter coagulation home monitoring market
16/01/2017 Market Update
10/01/2017 ASX Market Release – Admission to the Official List

LifeSpot Health Log white small

Lifespot Health Ltd
ACN 611 845 820

Suite 103 Level 1
2 Queen Street
Melbourne 3000

CONTACT US

(03) 8395 5446
info@lifespot-health.com

LEGAL

Terms of Use
Privacy Policy

Disclaimer: Please ensure you seek advice from your doctor in addition to using this app and before making any medical decisions.

  • Facebook
  • Twitter
  • Google
  • RSS

Site and Marketing by Platform